Key Takeaways
- • Suki, a Redwood City, California-based leader in Ambient Clinical Intelligence (ACI), announced $90 million in financing as part of its Series E round.
- • The round is intended to accelerate growth and expand the company's healthcare AI capabilities.
- • New investors include Healthier Capital, Crosslink Capital, and Hercules Capital.
- • All existing institutional investors participated, including Venrock, Flare Capital Partners, Hedosophia, Philips Ventures, and Zoom Ventures.
Summary
Suki, which describes itself as a leader in Ambient Clinical Intelligence (ACI), announced $90 million in financing as part of its Series E round, according to a company announcement published by Massinvestor on October 19, 2026. The Redwood City, California-based company said the capital will be used to accelerate growth and expand its healthcare AI capabilities.
The financing brings in three new investors: Healthier Capital, Crosslink Capital, and Hercules Capital. Existing institutional investors also participated in the round, including Venrock, Flare Capital Partners, Hedosophia, Philips Ventures, and Zoom Ventures, indicating continued backing from the company's earlier financing partners.
The source material does not disclose a valuation, the lead investor, or detailed product or revenue metrics. Ambient clinical intelligence refers to AI tools that capture and process clinical encounters in the background to support documentation and workflow, and Suki's positioning places it within the healthcare AI segment, which continues to attract growth-stage capital.
The financing brings in three new investors: Healthier Capital, Crosslink Capital, and Hercules Capital. Existing institutional investors also participated in the round, including Venrock, Flare Capital Partners, Hedosophia, Philips Ventures, and Zoom Ventures, indicating continued backing from the company's earlier financing partners.
The source material does not disclose a valuation, the lead investor, or detailed product or revenue metrics. Ambient clinical intelligence refers to AI tools that capture and process clinical encounters in the background to support documentation and workflow, and Suki's positioning places it within the healthcare AI segment, which continues to attract growth-stage capital.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.